SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: A meta-analysis of randomised controlled trials.

Akash Jaiswal,Vikash Jaiswal,Song Peng Ang,Muhammad Hanif,Ananya Vadhera,Vibhor Agrawal,Tushar Kumar, Anagha M Nair,VamsikalyanReddy Borra,Vamsi Garimella,Angela Ishak,Zarghoona Wajid,David Song,Abdelrahman M Attia,Helen Huang, Victor Hugo Aguilera Alvarez,Abhigan Babu Shrestha,Monodeep Biswas

Medicine（2023）

引用 0|浏览6

暂无评分

摘要

Our study finding shows that SGLT2 inhibitors significantly reduced the risk of first HF hospitalization or cardiovascular death and HF hospitalization; however, all-cause mortality was comparable between the groups.

查看译文

关键词

cardiovascular outcomes, heart failure, SGLT2 inhibitors

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要